Bogart Wealth LLC
CTXR icon

Bogart Wealth LLC’s Citius Pharmaceuticals CTXR Stock Holding History

Bogart Wealth LLC’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
4
– – ﹤0.01% 2006
2026
Q1 		$4 Buy
+4
New +$3 ﹤0.01% 1812

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Miller Financial Services
Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Asset Advisory Group
Asset Advisory Group Kinnelon, New Jersey $232M AUM 16.51% 1-Year Est. Return

Bogart Wealth LLC's CTXR Position: Q2 2026 in Review

Bogart Wealth LLC held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 4 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Bogart Wealth LLC first reported a position in CTXR in Q1 2026 and has held it in 2 quarters since. The position peaked at $4 in Q1 2026. 42 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Bogart Wealth LLC held 4 shares of Citius Pharmaceuticals worth $2 as of Q2 2026.
  • Bogart Wealth LLC left its Citius Pharmaceuticals share count unchanged in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #2006 holding.
  • Bogart Wealth LLC first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Bogart Wealth LLC's Citius Pharmaceuticals position peaked at $4 in Q1 2026.
  • 42 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.